| Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13 MJ Seraj, RS Samant, MF Verderame, DR Welch Cancer research 60 (11), 2764-2769, 2000 | 418 | 2000 |
| Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis W Yue, RJ Santen, JP Wang, Y Li, MF Verderame, WP Bocchinfuso, ... The Journal of steroid biochemistry and molecular biology 86 (3-5), 477-486, 2003 | 366 | 2003 |
| The biology of the opioid growth factor receptor (OGFr) IS Zagon, MF Verderame, PJ McLaughlin Brain Research Reviews 38 (3), 351-376, 2002 | 363 | 2002 |
| Shared and distinct functions of RAGS and ELF‐1 in guiding retinal axons B Monschau, C Kremoser, K Ohta, H Tanaka, T Kaneko, T Yamada, ... The EMBO journal, 1997 | 316 | 1997 |
| Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription WJ Meehan, RS Samant, JE Hopper, MJ Carrozza, LA Shevde, ... Journal of Biological Chemistry 279 (2), 1562-1569, 2004 | 227 | 2004 |
| Cytoskeletal F-actin patterns quantitated with fluorescein isothiocyanate-phalloidin in normal and transformed cells. M Verderame, D Alcorta, M Egnor, K Smith, R Pollack Proceedings of the National Academy of Sciences 77 (11), 6624-6628, 1980 | 219 | 1980 |
| WW domains and retrovirus budding L Gamier, JW Wills, MF Verderame, M Sudol Nature 381 (6585), 744-745, 1996 | 166 | 1996 |
| Analysis of mechanisms underlying BRMS1 suppression of metastasis RS Samant, MJ Seraj, MM Saunders, TS Sakamaki, LA Shevde, JF Harms, ... Clinical & experimental metastasis 18, 683-693, 2000 | 157 | 2000 |
| The OGF–OGFr Axis Utilizes the p16INK4a and p21WAF1/CIP1 Pathways to Restrict Normal Cell Proliferation F Cheng, PJ McLaughlin, MF Verderame, IS Zagon Molecular biology of the cell 20 (1), 319-327, 2009 | 135 | 2009 |
| Opioid growth factor regulates the cell cycle of human neoplasias. IS Zagon, CD Roesener, MF Verderame, BM Ohlsson-Wilhelm, RJ Levin, ... International journal of oncology 17 (5), 1053-1114, 2000 | 106 | 2000 |
| Actin cytoskeletal organization loss in the benign-to-malignant tumor transition in cultured human colonic epithelial cells E Friedman, M Verderame, S Winawer, R Pollack Cancer Research 44 (7), 3040-3050, 1984 | 105 | 1984 |
| The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer F Cheng, PJ McLaughlin, MF Verderame, IS Zagon Molecular cancer 7, 1-12, 2008 | 93 | 2008 |
| Characterization of the CCK-C (cancer) receptor in human pancreatic cancer JP Smith, MF Verderame, P McLaughlin, M Martenis, E Ballard, IS Zagon International journal of molecular medicine 10 (6), 689-694, 2002 | 92* | 2002 |
| Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans IS Zagon, MF Verderame, SS Allen, PJ McLaughlin Brain research 856 (1-2), 75-83, 2000 | 91 | 2000 |
| Identification and characterization of the murine ortholog (brms1) of breast‐cancer metastasis suppressor 1 (BRMS1) RS Samant, MT Debies, LA Shevde, MF Verderame, DR Welch International journal of cancer 97 (1), 15-20, 2002 | 89 | 2002 |
| The membrane-binding domain of the Rous sarcoma virus Gag protein MF Verderame, TD Nelle, JW Wills Journal of virology 70 (4), 2664-2668, 1996 | 75 | 1996 |
| A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner MF Verderame, JM Kaplan, HE Varmus Journal of virology 63 (1), 338-348, 1989 | 72 | 1989 |
| The opioid growth factor (OGF)–OGF receptor axis uses the p16 pathway to inhibit head and neck cancer F Cheng, IS Zagon, MF Verderame, PJ McLaughlin Cancer Research 67 (21), 10511-10518, 2007 | 68 | 2007 |
| Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma IS Zagon, JR Jaglowski, MF Verderame, JP Smith, AE Leure-duPree, ... Cancer chemotherapy and pharmacology 56, 510-520, 2005 | 64 | 2005 |
| Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells A Manni, S Washington, JW Griffith, MF Verderame, D Mauger, ... Clinical & experimental metastasis 19, 95-105, 2002 | 63 | 2002 |
Robert Pollackprofessor of biological sciences, columbia universityVerified email at columbia.edu
